1. Home
  2. LE vs ORGO Comparison

LE vs ORGO Comparison

Compare LE & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lands' End Inc.

LE

Lands' End Inc.

HOLD

Current Price

$12.00

Market Cap

334.7M

ML Signal

HOLD

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

HOLD

Current Price

$2.55

Market Cap

348.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LE
ORGO
Founded
1963
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
334.7M
348.6M
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
LE
ORGO
Price
$12.00
$2.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$32.50
$8.50
AVG Volume (30 Days)
579.2K
1.5M
Earning Date
06-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1600.00
EPS
0.18
0.15
Revenue
$1,162,769,000.00
$564,169,000.00
Revenue This Year
$5.53
N/A
Revenue Next Year
$2.48
$26.27
P/E Ratio
$64.17
$17.33
Revenue Growth
0.72
17.04
52 Week Low
$7.65
$2.21
52 Week High
$20.04
$7.08

Technical Indicators

Market Signals
Indicator
LE
ORGO
Relative Strength Index (RSI) 45.22 48.21
Support Level $11.16 $2.26
Resistance Level $13.83 $2.57
Average True Range (ATR) 0.76 0.17
MACD 0.19 0.08
Stochastic Oscillator 46.01 72.54

Price Performance

Historical Comparison
LE
ORGO

About LE Lands' End Inc.

Lands' End Inc is a United States-based digital retailer of solution-based apparel, swimwear, outerwear, accessories, footwear, home products, and uniforms. It offers products online at the website (www.landsend.com), through third-party distribution channels, its own company-operated stores, and third-party license agreements. Lands' End also offers products to businesses and schools, for their employees and students, through the Outfitters distribution channel. The company's operating segments consist of: U.S. eCommerce, Europe eCommerce, Outfitters, Third Party, Licensing, and Retail. The majority of its revenue is generated from the U.S. eCommerce segment. Geographically, Lands' End derives maximum revenue from the United States, and the rest from Europe and other markets.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: